Horizon Kinetics’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
$2.23M Sell
19,254
-2,000
-9% -$223K 0.07% 101
2018
Q3
$2.28M Sell
21,254
-1,328
-6% -$133K 0.06% 107
2018
Q2
$1.93M Sell
22,582
-1,500
-6% -$123K 0.05% 121
2018
Q1
$1.86M Sell
24,082
-1,000
-4% -$80.5K 0.05% 126
2017
Q4
$2.12M Hold
25,082
0.06% 118
2017
Q3
$2.15M Sell
25,082
-365
-1% -$29.9K 0.06% 112
2017
Q2
$2.1M Buy
25,447
+356
+1% +$29K 0.07% 118
2017
Q1
$2.11M Sell
25,091
-1,525
-6% -$122K 0.07% 117
2016
Q4
$1.96M Sell
26,616
-2,000
-7% -$149K 0.06% 117
2016
Q3
$2.3M Sell
28,616
-1,453
-5% -$116K 0.06% 117
2016
Q2
$2.37M Hold
30,069
0.06% 119
2016
Q1
$2.17M Sell
30,069
-378
-1% -$28.6K 0.05% 115
2015
Q4
$2.56M Hold
30,447
0.06% 111
2015
Q3
$2.55M Hold
30,447
0.05% 119
2015
Q2
$2.54M Hold
30,447
0.04% 142
2015
Q1
$2.21M Sell
30,447
-30
-0.1% -$2.14K 0.03% 155
2014
Q4
$2.1M Buy
30,477
+30
+0.1% +$2.02K 0.03% 165
2014
Q3
$1.98M Hold
30,447
0.03% 162
2014
Q2
$1.89M Sell
30,447
-350
-1% -$20.9K 0.02% 171
2014
Q1
$1.81M Buy
30,797
+137
+0.4% +$7.65K 0.02% 174
2013
Q4
$1.56M Sell
30,660
-5,300
-15% -$265K 0.02% 190
2013
Q3
$1.81M Hold
35,960
0.02% 165
2013
Q2
$1.77M Buy
+35,960
New +$1.96M 0.03% 172

Other funds holding LLY

Horizon Kinetics's LLY Position: Q4 2018 in Review

Horizon Kinetics reduced its Eli Lilly (LLY) stake by 9.4% in Q4 2018, selling an estimated $223K and leaving 19,254 shares worth $2.23M. The position accounts for 0.07% of the portfolio, ranked #101.

Horizon Kinetics first reported a position in LLY in Q2 2013 and has held it in 23 quarters since. The position peaked at $2.56M in Q4 2015. 1,561 funds tracked by Wall St. Rank hold LLY as of Q4 2018.

  • Horizon Kinetics held 19,254 shares of Eli Lilly worth $2.23M as of Q4 2018.
  • Horizon Kinetics sold 2,000 Eli Lilly shares in Q4 2018, an estimated $223K.
  • Eli Lilly made up 0.07% of Horizon Kinetics's portfolio in Q4 2018, its #101 holding.
  • Horizon Kinetics first reported a position in Eli Lilly in Q2 2013 and has held it in 23 quarters since.
  • Horizon Kinetics's Eli Lilly position peaked at $2.56M in Q4 2015.
  • 1,561 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2018.

Based on Horizon Kinetics's 13F filing for Q4 2018, filed 14 Feb 2019.